Effects of cathepsin K deficiency on intercellular junction proteins, luminal mucus layers, and extracellular matrix constituents in the mouse colon

Biological Chemistry

Volumn 393, Issue 12, 2012, Pages 1391-1403

  Arampatzidou, Maria ^a   Schute, Andre ^b   Hansson, Gunnar C ^b   Saftig, Paul ^c   Brix, Klaudia ^a  

^a JACOBS UNIVERSITY BREMEN   (Germany)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Colon; Cysteine cathepsins; Intercellular junctions; Intestinal barrier; Mucus

Indexed keywords

CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; CATHEPSIN X; CLAUDIN 1; COLLAGEN TYPE 4; COLLAGENASE; ELASTASE; LAMININ; MUCIN 2; OCCLUDIN; UVOMORULIN;

ANIMAL EXPERIMENT; CELL MEMBRANE; CELLULAR DISTRIBUTION; COLON MUCOSA; CONFERENCE PAPER; CONTROLLED STUDY; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; CADHERINS; CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; COLON; EXTRACELLULAR MATRIX; GENE DELETION; INTERCELLULAR JUNCTIONS; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; OCCLUDIN; PROTEOLYSIS;

MUS;

EID: 84869404265     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0204     Document Type: Conference Paper

References (53)

1. Arampatzidou, M., Mayer, K., Lolyeva, M.E., Asrat, S.G., Ravichandran, M., Gunther, T., Schule, R., Reinheckel, T., and Brix, K. (2011a). Studies of intestinal morphology and cathepsin B expression in a transgenic mouse aiming at intestine-specific expression of Cath B-EGFP. Biol. Chem. 392, 983-993.
2. Arampatzidou, M., Rehders, M., Dauth, S., Yu, D.M., Tedelind, S., and Brix, K. (2011b). Imaging of protease functions-current guide to spotting cysteine cathepsins in classical and novel scenes of action in mammalian epithelial cells and tissues. Ital. J. Anat. Embryol. 116, 1-19.
3. Backhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., and Gordon, J.I. (2005). Host-bacterial mutualism in the human intestine. Science 307, 1915-1920.
4. Boudreau, F., Lussier, C.R., Mongrain, S., Darsigny, M., Drouin, J.L., Doyon, G., Suh, E.R., Beaulieu, J.F., Rivard, N., and Perreault, N. (2007). Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia. Faseb J. 21, 3853-3865.
5. Brix, K., Dunkhorst, A., Mayer, K., and Jordans, S. (2008). Cysteine cathepsins: cellular roadmap to different functions. Biochimie 90, 194-207.
6. Bromme, D. (2011). Cysteine cathepsins and the skeleton. Clin. Rev. Bone Miner. Metab. 9, 83-93.
7. Bromme, D. and Okamoto, K. (1995). Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol. Chem. Hoppe Seyler 376, 379-384.
8. Dauth, S., Arampatzidou, M., Rehders, M., Yu, D., Fuhrer, D., and Brix, K. (2011a). Thyroid cathepsin K-roles in physiology and thyroid disease. Clin. Rev. Bone Miner. Metab. 9, 94-106.
9. Dauth, S., Sirbulescu, R.F., Jordans, S., Rehders, M., Avena, L., Oswald, J., Lerchl, A., Saftig, P., and Brix, K. (2011b). Cathepsin K deficiency in mice induces structural and metabolic changes in the central nervous system that are associated with learning and memory deficits. BMC Neurosci. 12, 74.
10. Deaton, D.N. and Tavares, F.X. (2005). Design of cathepsin K inhibitors for osteoporosis. Curr. Top. Med. Chem. 5, 1639-1675.
11. Desmarais, S., Black, W.C., Oballa, R., Lamontagne, S., Riendeau, D., Tawa, P., Duong le, T., Pickarski, M., and Percival, M.D. (2008). Effect of cathepsin K inhibitor basicity on in vivo off-target activities. Mol. Pharmacol. 73, 147-156.
12. Desmarais, S., Masse, F., and Percival, M.D. (2009). Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools. Biol. Chem. 390, 941-948.
13. Friedrichs, B., Tepel, C., Reinheckel, T., Deussing, J., von Figura, K., Herzog, V., Peters, C., Saftig, P., and Brix, K. (2003). Thyroid functions of mouse cathepsins B, K, and L. J. Clin. Invest. 111, 1733-1745.
14. Gassler, N., Rohr, C., Schneider, A., Kartenbeck, J., Bach, A., Obermuller, N., Otto, H.F., and Autschbach, F. (2001). Inflammatory bowel disease is associated with changes of enterocytic junctions. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G216-G228.
15. Gauthier, J.Y., Chauret, N., Cromlish, W., Desmarais, S., Duongle, T., Falgueyret, J.P., Kimmel, D.B., Lamontagne, S., Leger, S., LeRiche, T., et al. (2008). The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg. Med. Chem. Lett. 18, 923-928.
16. Gelb, B.D., Shi, G.P., Chapman, H.A., and Desnick, R.J. (1996). Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236-1238.
17. Gibson, P., Rosella, O., Nov, R., and Young, G. (1995). Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer. Gut 36, 857-863.
18. Gocheva, V., Zeng, W., Ke, D., Klimstra, D., Reinheckel, T., Peters, C., Hanahan, D., and Joyce, J.A. (2006). Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20, 543-556.
19. Gustafsson, J.K., Ermund, A., Johansson, M.E., Schutte, A., Hansson, G.C., and Sjovall, H. (2011). An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G430-G438.
20. Haeckel, C., Krueger, S., Buehling, F., Broemme, D., Franke, K., Schuetze, A., Roese, I., and Roessner, A. (1999). Expression of cathepsin K in the human embryo and fetus. Dev. Dyn. 216, 89-95.
21. Hanby, A.M., Chinery, R., Poulsom, R., Playford, R.J., and Pignatelli, M. (1996). Downregulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract. Am. J. Pathol. 148, 723-729.
22. Howell, S., Brewis, I.A., Hooper, N.M., Kenny, A.J., and Turner, A.J. (1993). Mosaic expression of membrane peptidases by confluent cultures of Caco-2 cells. FEBS Lett. 317, 109-112.
23. Johansson, M.E., Phillipson, M., Petersson, J., Velcich, A., Holm, L., and Hansson, G.C. (2008). The inner of the two Muc2 mucindependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 105, 15064-15069.
24. Johansson, M.E., Ambort, D., Pelaseyed, T., Schutte, A., Gustafsson, J.K., Ermund, A., Subramani, D.B., Holmen-Larsson, J.M., Thomsson, K.A., Bergstrom, J.H., et al. (2011a). Composition and functional role of the mucus layers in the intestine. Cell. Mol. Life Sci. 68, 3635-3641.
25. Johansson, M.E., Larsson, J.M., and Hansson, G.C. (2011b). The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. USA 108 (Suppl 1), 4659-4665.
26. Jordans, S., Jenko-Kokalj, S., Kuhl, N.M., Tedelind, S., Sendt, W., Bromme, D., Turk, D., and Brix, K. (2009). Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions. BMC Biochem. 10, 23.
27. Karayiannakis, A.J., Syrigos, K.N., Efstathiou, J., Valizadeh, A., Noda, M., Playford, R.J., Kmiot, W., and Pignatelli, M. (1998). Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease. J. Pathol. 185, 413-418.
28. Lewiecki, E.M. (2009). Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling. IDrugs 12, 799-809.
29. Lidell, M.E., Moncada, D.M., Chadee, K., and Hansson, G.C. (2006). Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proc. Natl. Acad. Sci. USA 103, 9298-9303.
30. Lien, W.H., Klezovitch, O., and Vasioukhin, V. (2006). Cadherincatenin proteins in vertebrate development. Curr. Opin. Cell Biol. 18, 499-506.
31. Mahoney, Z.X., Stappenbeck, T.S., and Miner, J.H. (2008). Laminin α5 influences the architecture of the mouse small intestine mucosa. J. Cell Sci. 121, 2493-2502.
32. Mayer, K., Schwartz, S., Lentze, M.J., Kalff, J.C., and Brix, K. (2006). Extracellular localization of intestinal cathepsins: implications of their actions during post-operative ileus. In: XLI Congress of the European Society for Surgical Research, B. Vollmar, ed. (Rostock, Germany: Medimond International Proceedings), pp. 63-66.
33. Mayer, K., Vreemann, A., Qu, H., and Brix, K. (2009). Release of endo-lysosomal cathepsins B, D, and L from IEC6 cells in a cell culture model mimicking intestinal manipulation. Biol. Chem. 390, 471-480.
34. Medina, C. and Radomski, M.W. (2006). Role of matrix metalloproteinases in intestinal inflammation. J. Pharmacol. Exp. Ther. 318, 933-938.
35. Menzel, K., Hausmann, M., Obermeier, F., Schreiter, K., Dunger, N., Bataille, F., Falk, W., Scholmerich, J., Herfarth, H., and Rogler, G. (2006). Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo . Clin. Exp. Immunol. 146, 169-180.
36. Mina-Osorio, P. (2008). The moonlighting enzyme CD13: old and new functions to target. Trends Mol. Med. 14, 361-371.
37. Neuhoff, V., Philipp, K., Zimmer, H.G., and Mesecke, S. (1979). A simple, versatile, sensitive and volume-independent method for quantitative protein determination which is independent of other external influences. Hoppe Seylers Z. Physiol. Chem. 360, 1657-1670.
38. Noth, R., Lange-Grumfeld, J., Stuber, E., Kruse, M.L., Ellrichmann, M., Hasler, R., Hampe, J., Bewig, B., Rosenstiel, P., Schreiber, S., et al. (2011). Increased intestinal permeability and tight junction disruption by altered expression and localization of occludin in a murine graft versus host disease model. BMC Gastroenterol. 11, 109.
39. Paris, L., Tonutti, L., Vannini, C., and Bazzoni, G. (2008). Structural organization of the tight junctions. Biochim. Biophys. Acta 1778, 646-659.
40. Podgorski, I. (2009). Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis? Future Med. Chem. 1, 21-34.
41. Poritz, L.S., Harris, L.R., 3rd, Kelly, A.A., and Koltun, W.A. (2011). Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig. Dis. Sci. 56, 2802-2809.
42. Punturieri, A., Filippov, S., Allen, E., Caras, I., Murray, R., Reddy, V., and Weiss, S.J. (2000). Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J. Exp. Med. 192, 789-799.
43. Rachner, T.D., Khosla, S., and Hofbauer, L.C. (2011). Osteoporosis: now and the future. Lancet 377, 1276-1287.
44. Reiser, J., Adair, B., and Reinheckel, T. (2010). Specialized roles for cysteine cathepsins in health and disease. J. Clin. Invest. 120, 3421-3431.
45. Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde, A., Rommerskirch, W., Moritz, J.D., Schu, P., and von Figura, K. (1998). Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. USA 95, 13453-13458.
46. Schmitz, H., Barmeyer, C., Fromm, M., Runkel, N., Foss, H.D., Bentzel, C.J., Riecken, E.O., and Schulzke, J.D. (1999). Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116, 301-309.
47. Sina, C., Lipinski, S., Gavrilova, O., Aden, K., Rehman, A., Till, A., Rittger, A., Podschun, R., Meyer-Hoffert, U., Haesler, R., et al. (2012). Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice. Gut. DOI 10.1136/gutjnl-2011- 300076.
48. Srivastava, M., Steinwede, K., Kiviranta, R., Morko, J., Hoymann, H.G., Langer, F., Buhling, F., Welte, T., and Maus, U.A. (2008). Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycininduced pulmonary fibrosis. Respir. Res. 9, 54.
49. Tepel, C., Bromme, D., Herzog, V., and Brix, K. (2000). Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin. J. Cell Sci. 113 Pt 24, 4487-4498.
50. Timpl, R. (1996). Macromolecular organization of basement membranes. Curr. Opin. Cell Biol. 8, 618-624.
51. Vreemann, A., Qu, H., Mayer, K., Andersen, L.B., Stefana, M.I., Wehner, S., Lysson, M., Farcas, A.M., Peters, C., Reinheckel, T., et al. (2009). Cathepsin B release from rodent intestine mucosa due to mechanical injury results in extracellular matrix damage in early post-traumatic phases. Biol. Chem. 390, 481-492.
52. Yang, M., Sun, J., Zhang, T., Liu, J., Zhang, J., Shi, M.A., Darakhshan, F., Guerre-Millo, M., Clement, K., Gelb, B.D., et al. (2008). Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arterioscler. Thromb. Vasc. Biol. 28, 2202-2208.
53. Yasuda, Y., Kaleta, J., and Bromme, D. (2005). The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv. Drug Deliv. Rev. 57, 973-993.